Effect of Ranolazine on Arrhythmias and Microvolt T- Wave Alternans (MVTWA) Patients With LV Dysfunction

NCT00998218 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

7

Enrollment

OTHER

Sponsor class

Conditions

Sudden Cardiac Death
Ventricular Arrythmias

Interventions

DRUG: Ranolazine
DRUG: Placebo

Sponsor

Aspirus Heart and Vascular Institute-Research and Education